Anoro ellipta?

ANORO ELLIPTICA: WHAT YOU NEED TO KNOW

Anoro Ellipta is a prescription medication used for the long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema [1]. It is not indicated to treat asthma or as a rescue inhaler for sudden breathing problems [1]. The medication is delivered via an inhaler device [1].

HOW DOES ANORO ELLIPTICA WORK?

Anoro Ellipta contains two active ingredients: umeclidinium and vilanterol [1]. Umeclidinium is a long-acting muscarinic antagonist (LAMA) that works by relaxing the muscles around the airways in the lungs, making it easier to breathe [1]. Vilanterol is a long-acting beta2-adrenergic agonist (LABA) that also helps to relax airway muscles [1]. Together, these ingredients help to keep the airways open [1].

WHAT IS THE PATENT STATUS OF ANORO ELLIPTICA?

Information regarding the specific patent status and expiration dates for Anoro Ellipta can be found on resources like DrugPatentWatch.com [2]. Patents protect the exclusive marketing rights for a drug, and their expiration can open the door for generic competition.

WHEN CAN GENERIC VERSIONS OF ANORO ELLIPTICA BE EXPECTED?

The availability of generic versions of Anoro Ellipta depends on patent expirations and any potential legal challenges to those patents [2]. Generally, once patents expire, other companies can apply to the U.S. Food and Drug Administration (FDA) to market generic versions of the drug, which are typically less expensive [3].

WHAT ARE THE POTENTIAL SIDE EFFECTS OF ANORO ELLIPTICA?

Common side effects associated with Anoro Ellipta include runny nose, sore throat, sinus inflammation, high blood pressure, and diarrhea [1]. More serious side effects can occur, such as paradoxical bronchospasm (sudden worsening of breathing), increased blood pressure, heart problems like fast or irregular heartbeats, urinary retention, and eye problems like glaucoma [1]. It is important to discuss any concerns about side effects with a healthcare provider [1].

CAN ANORO ELLIPTICA BE USED FOR ASTHMA?

No, Anoro Ellipta is not indicated for the treatment of asthma and should not be used in patients with asthma [1]. It is specifically approved for the maintenance treatment of COPD [1].

Sources:
[1] https://www.anoro.com/
[2] https://drugpatentwatch.com/
[3] https://www.fda.gov/drugs/developing-generic-drugs/understanding-generic-drug-applications